Suggestions

Du même auteur

Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial

Archive ouverte | Delforge, Michel | CCSD

International audience

Idecabtagene vicleucel in relapsed and refractory multiple myeloma

Archive ouverte | Munshi, Nikhil C. | CCSD

International audience. Idecabtagene vicleucel (ide-cel, also called bb2121), a B-cell maturation antigen-directed chimeric antigen receptor (CAR) T-cell therapy, has shown clinical activity with expected CAR T-cell...

Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide

Archive ouverte | Minuk, Leonard | CCSD

International audience. We compared the health-related quality-of-life of patients with newly diagnosed multiple myeloma aged over 65 years or transplant-ineligible in the pivotal, phase III FIRST trial. Patients re...

Chargement des enrichissements...